Materials Healthcare Sector

KORU Medical Systems

Market Cap: US$137.0m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Greenwich LifeSciences

Market Cap: US$135.1m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Pulmonx

Market Cap: US$134.5m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

Protalix BioTherapeutics

Market Cap: US$133.7m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

TerrAscend

Market Cap: CA$185.4m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Protara Therapeutics

Market Cap: US$131.9m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Vireo Growth

Market Cap: CA$181.8m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Lucid Diagnostics

Market Cap: US$130.4m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Compugen

Market Cap: US$130.0m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Nektar Therapeutics

Market Cap: US$129.3m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Oneview Healthcare

Market Cap: AU$201.3m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

InfuSystem Holdings

Market Cap: US$128.4m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

AOTI

Market Cap: UK£95.7m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

RAPT Therapeutics

Market Cap: US$128.0m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

Enanta Pharmaceuticals

Market Cap: US$127.4m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Scancell Holdings

Market Cap: UK£95.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Atossa Therapeutics

Market Cap: US$127.1m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Alector

Market Cap: US$127.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Jin Medical International

Market Cap: US$126.2m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

Editas Medicine

Market Cap: US$124.7m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

eXoZymes

Market Cap: US$124.7m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

Larimar Therapeutics

Market Cap: US$124.5m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Seer

Market Cap: US$123.7m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Myomo

Market Cap: US$123.0m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Lyell Immunopharma

Market Cap: US$122.0m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Nkarta

Market Cap: US$120.6m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Theratechnologies

Market Cap: CA$167.4m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Black Diamond Therapeutics

Market Cap: US$120.0m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

InflaRx

Market Cap: US$119.9m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Sangamo Therapeutics

Market Cap: US$118.4m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Vigil Neuroscience

Market Cap: US$116.2m

A clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States.

Achieve Life Sciences

Market Cap: US$114.8m

A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.

Vaxart

Market Cap: US$113.9m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.

ACC Aviation Holdings

Market Cap: US$113.8m

Focuses on developing canna powder products.

American Well

Market Cap: US$113.8m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

Lineage Cell Therapeutics

Market Cap: US$113.6m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.